Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Italy“
Suchtreffer
Begriffe & Kennungen
Briviact (in Italy: Nubriveo) · 4.8 · Adverse reactions with intravenous administration generally appeared to be similar to those observed with oral
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Description of selected adverse reactions
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Description of selected adverse reactions
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Description of selected adverse reactions
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · In the table below, adverse reactions, which were identified based on review of the three placebo- controlled,
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · In the table below, adverse reactions, which were identified based on review of the three placebo- controlled,
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · In the table below, adverse reactions, which were identified based on review of the three placebo- controlled,
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Neutropenia has been reported in 0.5 % (6/1,099) brivaracetam patients and 0 % (0/459) placebo patients. Four
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Neutropenia has been reported in 0.5 % (6/1,099) brivaracetam patients and 0 % (0/459) placebo patients. Four
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Neutropenia has been reported in 0.5 % (6/1099) brivaracetam patients and 0 % (0/459) placebo patients. Four o
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · No specific pattern of adverse event (AE) was identified in children from 1◦month to < 4◦years of age when com
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · No specific pattern of adverse event (AE) was identified in children from 1◦month to < 4◦years of age when com
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Of the 130 elderly subjects enrolled in the brivaracetam phase 2/3 development program (44 with epilepsy), 100
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Of the 130 elderly subjects enrolled in the brivaracetam phase 2/3 development program (44 with epilepsy), 100
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Of the 130 elderly subjects enrolled in the brivaracetam phase 2/3 development program (44 with epilepsy), 100
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Paediatric population
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Paediatric population
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Paediatric population
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Reactions suggestive of immediate (Type I) hypersensitivity have been reported in a small number of brivaracet
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · Reactions suggestive of immediate (Type I) hypersensitivity have been reported in a small number of brivaracet
Eintrag öffnen